Cornel iridoid glycoside inhibits tau pathology via regulating cross-talk between GSK-3beta and PP2A signaling

Cuicui Yang,Li Zhang,Yali Li,Lan Zhang,Lin Li
DOI: https://doi.org/10.1254/jpssuppl.wcp2018.0_po2-12-13
2018-01-01
Proceedings for Annual Meeting of The Japanese Pharmacological Society
Abstract:Neurofibrillary pathology contributes toneuronal dysfunction and correlates with the clinical progression of Alzheimer's disease (AD). Tau phosphorylation is mainly regulated by a balance of glycogen synthase kinase-3beta(GSK-3beta) and protein phosphatase 2A (PP2A) activities. Cornel iridoid glycoside(CIG) is a main component extracted from Cornus offcinalis.
What problem does this paper attempt to address?